Geneos Wealth Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.92K Sell
79
-113
-59% -$14.2K ﹤0.01% 2333
2025
Q1
$26.3K Buy
192
+104
+118% +$14.2K ﹤0.01% 2218
2024
Q4
$13.5K Sell
88
-9
-9% -$1.38K ﹤0.01% 1920
2024
Q3
$18.8K Sell
97
-137
-59% -$26.6K ﹤0.01% 1581
2024
Q2
$54.2K Sell
234
-7
-3% -$1.62K ﹤0.01% 1042
2024
Q1
$52K Sell
241
-109
-31% -$23.5K ﹤0.01% 1051
2023
Q4
$90.6K Hold
350
﹤0.01% 867
2023
Q3
$90K Sell
350
-80
-19% -$20.6K ﹤0.01% 902
2023
Q2
$122K Buy
430
+200
+87% +$57K 0.01% 825
2023
Q1
$63.9K Hold
230
﹤0.01% 997
2022
Q4
$63.7K Sell
230
-55
-19% -$15.2K ﹤0.01% 964
2022
Q3
$76K Sell
285
-1,150
-80% -$307K 0.01% 878
2022
Q2
$302K Sell
1,435
-1
-0.1% -$210 0.01% 619
2022
Q1
$302K Sell
1,436
-274
-16% -$57.6K 0.01% 667
2021
Q4
$410K Buy
1,710
+114
+7% +$27.3K 0.02% 643
2021
Q3
$453K Buy
1,596
+187
+13% +$53.1K 0.02% 595
2021
Q2
$491K Sell
1,409
-2,179
-61% -$759K 0.02% 566
2021
Q1
$959K Sell
3,588
-269
-7% -$71.9K 0.03% 432
2020
Q4
$1.03M Buy
3,857
+2,578
+202% +$686K 0.04% 339
2020
Q3
$349K Sell
1,279
-25
-2% -$6.82K 0.02% 519
2020
Q2
$337K Buy
1,304
+86
+7% +$22.2K 0.02% 513
2020
Q1
$361K Sell
1,218
-183
-13% -$54.2K 0.02% 441
2019
Q4
$420K Buy
1,401
+183
+15% +$54.9K 0.02% 482
2019
Q3
$280K Sell
1,218
-920
-43% -$211K 0.02% 550
2019
Q2
$500K Buy
2,138
+12
+0.6% +$2.81K 0.03% 404
2019
Q1
$502K Sell
2,126
-9
-0.4% -$2.13K 0.03% 392
2018
Q4
$626K Sell
2,135
-11
-0.5% -$3.23K 0.05% 329
2018
Q3
$758K Buy
2,146
+221
+11% +$78.1K 0.05% 306
2018
Q2
$558K Sell
1,925
-271
-12% -$78.6K 0.04% 310
2018
Q1
$601K Sell
2,196
-103
-4% -$28.2K 0.05% 276
2017
Q4
$732K Sell
2,299
-50
-2% -$15.9K 0.07% 259
2017
Q3
$735K Buy
2,349
+44
+2% +$13.8K 0.07% 240
2017
Q2
$625K Buy
2,305
+33
+1% +$8.95K 0.06% 254
2017
Q1
$621K Sell
2,272
-197
-8% -$53.8K 0.06% 233
2016
Q4
$700K Buy
2,469
+96
+4% +$27.2K 0.09% 202
2016
Q3
$742K Sell
2,373
-17
-0.7% -$5.32K 0.1% 196
2016
Q2
$585K Hold
2,390
0.08% 219
2016
Q1
$622K Buy
+2,390
New +$622K 0.1% 205